Imatinib Mesylate
Composition
Imatinib Mesylate tablets contain the active ingredient imatinib mesylate and excipients such as lactose monohydrate, microcrystalline cellulose, and magnesium stearate. These components ensure the drug's stability, effectiveness, and proper delivery in the body.
Indications
Used for the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and certain other malignancies.
Side effects
Possible side effects include edema, muscle cramps, and myelosuppression
Precautions
Monitor for signs of fluid retention and hematologic toxicity
Contraindications
Hypersensitivity to Imatinib Mesylate or any component, severe hepatic impairment.
Dosage and administration
As directed by oncologist
Countries
We have established our roots in other countries as well, such as Australia, Japan, Canada, and Brazil.
Available Forms
Tablets, Capsules
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai